T
Taysha Gene Therapies (TSHA)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Taysha Gene Therapies (TSHA)
Taysha Gene Therapies, Inc. is a patient-centric gene therapy company. The Company is focused on developing and commercializing adeno-associated virus (AAV)-based gene therapies for the treatment of monogenic diseases of the central nervous system (C... Read more
- USD2.58
- USD2.64
- USD2.49
- USD4.07
- 8.50%
- 7M
- 2.46M
- 5.12M
- 715M
- 1.05
- -39.10%
Stock News
2 hours ago
3 reasons that bitcoin in your 401(k) is still a terrible idea
MarketWatch
3 hours ago
Roblox Insiders Sell US$33m Of Stock, Possibly Signalling Caution
Yahoo
6 hours ago
Iovance: Amtagvi's Rocky Launch And Mounting Concerns Lead To A 'Sell' Rating
SeekingAlpha
6 hours ago
Why I Will Never Retire
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
